GLPwatch
Papers (12034)
Page 201 of 201, ranked by citation count.
- Evaluation of the protective effects of liraglutide, dapagliflozin and their combination in rat kidneys of streptozotocin induced diabetes.
- Effectiveness of Liraglutide in Patients With Obesity Who Are Early Non-Responders to Lifestyle Intervention: A Real-World Study.
- Childhood Obesity, Medications, and Surgeries.
- GLP-1 Receptor Agonists in Hidradenitis Suppurativa: Time to Treat the Whole Patient.
- Association of GLP-1 receptor agonists with alcohol use disorder-related and substance use disorder-related hospital admissions during treatment and after discontinuation: a Swedish register-based within-individual observational study.
- Evaluating the managed care implications of longer-acting basal insulin analog therapies.
- Comparing Telepharmacy to Conventional Pharmacy Care: An Economic Evaluation.
- The role of nursing care in the type 2 diabetes treatment associated with chronic liver diseases.
- Ketoacidosis Risk in Non-diabetic Patients Using Semaglutide Versus Tirzepatide for Obesity: A Disproportionality Analysis of the FDA Adverse Event Reporting System.
- [Effects of Exendin-4 on the differentiation of neural stem cells from subventricular zone of adult mice in vitro].
- Exenatide challenge in oral glucose tolerance test is insufficient for predictions of glucose metabolism and insulin secretion after sleeve gastrectomy (SG) in obese patients with type 2 diabetes: a pilot study to establish a preoperative model to estimate β-cell function following augmented glucagon-like peptide-1 secretion after SG.
- Impact of Preoperative Semaglutide Discontinuation Timing on Postoperative Outcomes in Aesthetic Abdominoplasty: A Retrospective Comparative Study.
- Efficacy and safety of once-weekly insulins in type 2 diabetes: A systematic review and meta-analysis.
- Major Adverse Liver Outcomes With Tirzepatide and Injectable Semaglutide in Adults With Overweight or Obesity and Type 2 Diabetes.
- Nonscarring Alopecia in Adults Treated With GLP-1s: A Propensity Score Matched TriNetX Cohort Study.
- Exenatide and sitagliptin: pancreatitis and pancreatic cancer. Harms on the rise.
- Is semaglutide a better weight-management option than bariatric surgery for patients undergoing total knee arthroplasty?
- Understanding reasons for initiation and experience with tirzepatide among individuals with obesity or overweight: Results from the PERCEPTIONS survey.
- Effect of oral semaglutide on remnant-like lipoprotein cholesterol in patients with ischemic heart disease receiving statin therapy.
- Semaglutide ameliorates traumatic sepsis-induced cardiac injury by activating the March5-ACSL4 axis to suppress ferroptosis.
- Real-World Effectiveness and Safety of Tirzepatide in Type 1 Diabetes and Obesity: Impact on Glycaemia, Weight, and Cardiometabolic Risk Markers.
- Is Bariatric Surgery at Risk Due to Semaglutide?
- Efficacy and safety of different once-weekly glucagon-like peptide-1 receptor agonists-A systematic review and Bayesian network meta-analysis.
- Accidental intradermal injection of tirzepatide associated with increased adverse events.
- Correction: Clinical Implications of Mounjaro (Tirzepatide) for Breast Cancer Detection and Management: A Narrative Review.
- Prescription Sequence Symmetry Analysis of Glucagon-Like Peptide-1 Receptor Agonists and Neuropsychiatric Conditions.
- Semaglutide for treatment of intractable diarrhea of different etiologies: a case series of 30 patients.
- Effects of Tirzepatide on Metabolic Parameters in Patients with Psoriasis and Obesity: 24-Week Real-World Study.
- Small Intestine-Permeable Cyclic Peptide-Mediated Enhancement of Fc-Fusion Protein Absorption in Mice.
- Aktuelles zur Therapie mit GLP-1-Rezeptoragonisten bei Patienten mit Diabetes mellitus Typ 2.
- Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin-4-IgG4-Fc in healthy subjects: A phase 1, single-centre, randomized, double-blind, dose escalation study.
- Liraglutide for type 2 diabetes?
- Ectopic, hepatic GLP-1R agonism enhances the weight loss efficacy of GLP-1 analogues.
- Integrated Evidence from VigiBase and Clinical Trials: A Comprehensive Pharmacovigilance Analysis of Seven Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs).